Research on neuroprotective mechanisms aims to understand how the nervous system is protected from injury or degeneration. These studies commonly use animal models to explore the underlying biology and mechanisms that could lead to therapeutic advancements for human and animal neurological conditions.

This Research Topic welcomes contributions to the following key areas of research.

1. Molecular Mechanisms of Neuroprotection:
Antioxidants, neurotrophic factors, and heat shock proteins (HSPs) protect neurons from damage. After stress or injury, antioxidants neutralize free radicals and reactive oxygen species (ROS). Excessive ROS can damage lipids, proteins, and DNA, leading to cell death. BDNF, NGF, and GDNF have been shown to promote neuronal survival in animal models of neurodegeneration. HSPs help protect cells from stress by refolding damaged proteins and preventing aggregation. These proteins maintain cellular function and are linked to neuroprotection.

2. Neuroinflammation and Immune Responses:
Neuroinflammation can trigger neurodegeneration. Current research focuses on understanding how neuroinflammation protects or exacerbates neuronal damage. Microglia, the resident immune cells in the CNS, are central to this process, as they can adopt either a pro-inflammatory or anti-inflammatory phenotype after injury. Manipulating microglial activation may reduce harmful inflammation and promote repair and regeneration.

3. Stem Cells and Regeneration:
In certain species, the brain has an impressive capacity for regeneration. Research is uncovering the genetic and cellular mechanisms behind these regenerative abilities, including the role of neural stem cells. Understanding how these animals repair their brains could lead to new strategies for enhancing neurogenesis.

4. Hormonal and Genetic Factors:
Estrogen and testosterone have recognized neuroprotective effects. Estrogen, in particular, has been shown to reduce neuronal cell death and promote neurogenesis. Additionally, genetic factors can influence an animal's ability to withstand neurodegeneration. Studies of gene expression and genetic knockouts in animals are helping researchers identify key genes involved in neuroprotection and repair.

5. Preclinical Studies and Drug Development:
Testing potential therapeutic compounds that could slow or prevent neurodegeneration is pivotal for translational studies. Animal models are used to assess the efficacy of various drugs, including neuroprotective agents such as antioxidants, anti-inflammatory compounds, and small molecules that promote neurotrophic factor signaling.

6. Behavioral and Cognitive Assessments:
Animal studies often include behavioral and cognitive assessments to determine whether treatment leads to functional recovery. In rodent models, for example, tests like the Morris water maze, novel object recognition, or open field tests can help assess memory, learning, and motor function after brain injury or disease.

We also welcome contributions exploring promising future research areas such as gene therapy, exosome-based therapies, and nanotechnologies. Advances in gene-editing technologies like CRISPR/Cas9 have paved the way for innovative modifications of genetic pathways involved in neuroprotection. Exosomes, which are small vesicles that transport proteins, lipids, and RNA between cells, are being investigated as potential vehicles for delivering therapeutic molecules across the blood-brain barrier. Similarly, nanoparticles are being engineered for precise drug delivery to the brain. Animal studies are evaluating how these nanoparticles can be tailored to deliver neuroprotective agents directly to damaged neurons, with the aim of reducing side effects and enhancing treatment efficacy.

Are you interested in contributing a manuscript to this Research Topic?

Exploring Neuroprotective Mechanisms: From Molecular Pathways to Translational Strategies

Topic Coordinator